Abstract
Clinical research management (CRM) is a critical resource for the management of clinical trials and it requires proper evaluation. This article advances a model of evaluation that has three local levels, plus one global level, for evaluating the value of CRM. The primary level for evaluation is that of the study or processes level. The managerial or aggregate level concerns management of the portfolio of trials under the control of the CRM office. The third, often overlooked level of evaluation, is the strategic level, whose goal is encapsulated in the phrase, "doing the right trials, while doing trials right." The global ("plus one") evaluation level concerns the need to evaluate the ever-increasing number of multi-institutional and multinational studies. As there are host of evaluation metrics, this article provides representative examples of metrics at each level and provides methods that can aid in the selecting appropriate metrics for an organization.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 464-477 |
| Number of pages | 14 |
| Journal | Evaluation and the Health Professions |
| Volume | 36 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2013 |
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The contributions of David M. Dilts are supported by The National Cancer Institute (NCI) of the National Institutes of Health (NIH), Contract SAIC-F Agreement 13XS141 and Oregon Clinical & Translational Research Institute (OCTRI), Grant Number (UL1TR000128 from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS). The content of the article is the sole responsibility of the author and does not necessarily represent the official views of the NIH.
| Funders | Funder number |
|---|---|
| Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health | 13XS141 |
| National Institute of Health-National Cancer Institute | |
| National Center for Advancing Translational Sciences | UL1TR000128 |
| Oregon Clinical and Translational Research Institute |
Keywords
- CRM value
- global evaluation
- managerial evaluation
- strategic evaluation
ASJC Scopus subject areas
- Health Policy
Fingerprint
Dive into the research topics of 'A "Three-Plus-One" Evaluation Model for Clinical Research Management'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS